Federal Register
Notices
> Manufacturers 2008 >
Cambrex Charles City, Inc.
FR Doc E8-6386[Federal Register: March 28, 2008 (Volume 73, Number 61)]
[Notices] [Page 16712-16713] From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr28mr08-113]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated December 17, 2007, and published in the Federal Register on
December 27, 2007, (72 FR 73357-73358), Cambrex Charles City, Inc., 1205 11th
Street, Charles City, Iowa 50616, made application by renewal to the Drug
Enforcement Administration (DEA) to be registered as a bulk manufacturer of the
basic classes of controlled substances listed in schedule II:
Drug
|
Schedule
|
Amphetamine (1100)
|
II
|
Methamphetamine (1105)
|
II
|
Lisdexamfetamine (1205)
|
II
|
Methylphenidate (1724)
|
II
|
Phenylacetone (8501)
|
II
|
Codeine (9050)
|
II
|
Oxycodone (9143)
|
II
|
Hydromorphone (9150)
|
II
|
Dextropropoxyphene, bulk (non-dosage form) (9273)
|
II
|
Morphine (9300)
|
II
|
Thebaine (9333)
|
II
|
Sufentanil (9740)
|
II
|
Fentanyl (9801)
|
II
|
The company plans to manufacture the listed controlled substances in bulk for
sale to its customers.
No comments or objections have been received. DEA has considered the factors
in 21 U.S.C. 823(a) and determined that the registration of Cambrex Charles
City, Inc. to manufacture the listed basic classes of controlled substances is
consistent with the public interest at this time. DEA has investigated Cambrex
Charles City, Inc. to ensure that the company's registration is consistent with
the public interest. The investigation has included inspection and testing of
the company's
[[Page 16713]]
physical security systems, verification of the company's compliance with
State and local laws, and a review of the company's background and history.
Therefore, pursuant to 21
U.S.C. 823, and in accordance with 21
CFR 1301.33, the above named company is granted registration as a bulk
manufacturer of the basic classes of controlled substances listed.
Dated: March 19, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E8-6386 Filed 3-27-08; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
|